Generic manufacturer Mylan will not sell Dey L.P., its specialty pharmaceutical division. After a review, the company decided Dey L.P. would be positive for earnings through 2010.
Sun Pharma's branded prostate cancer treatment Yonsa just received FDA approval.
Amgen and Novartis enlisted Arnold Worldwide, Wavemaker, and Starcom Media Group for its Speak Your Migraine campaign.
Novocure and Glue Advertising put on a Facebook Live event promoting the cancer treatment Optune in March.